Skip to main content

Amrize Ltd

corporate_fare Company Profile

Amrize Ltd

AMRZ·NYSE·Manufacturing·CIK 0002035989

Amrize Ltd is a building solutions company focused on the North American market, providing a wide range of advanced building solutions from foundation to rooftop. The company generates revenue from selling cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. Amrize has over 19,000 employees operating across more than 1,000 sites, facilities, and corporate offices in the United States, Canada, Colombia, Switzerland, and Jamaica. It serves over 23,000 customers in the North American infrastructure, commercial, and residential construction markets. Specifically, Amrize provides cement, aggregates, ready-mix concrete materials, and advanced roofing and wall systems in the United States and Canada. The company maintains strategically located facilities and a large distribution network. On June 23, 2025, Holcim Ltd completed the Spin-Off of Amrize through a distribution of 100% of Amrize's outstanding shares to Holcim's ordinary shareholders as of June 20, 2025. As a result, Amrize now operates as a standalone public company. The company is organized into two reportable segments: Building Materials and Building Envelope. Its services cover both new construction and repair and refurbishment.

Amrize Ltd (NYSE:AMRZ) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 14 items for AMRZ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for AMRZ spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Amrize Q2 revenue climbs 8.6% to $3.49B, but material weakness and a prior-period revision persist
  • Amrize Guides 2026 Revenue to $12.5B-$12.7B, Above Consensus
  • Amrize lifts FY revenue target after 8.6% Q2 top-line gain, but trims EBITDA view on cost inflation
  • Amrize Expands Texas Footprint with Rapid Redi-Mix Acquisition
  • Amrize Breaks Ground on Major Cement Plant Modernization, Boosting Capacity 33%

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.81B
Net Income
$1.19B
Diluted EPS
$2.14
Op. Cash Flow
$2.21B
Free Cash Flow
$1.42B
Gross Profit
$3.03B
Operating Income
$1.91B
Cash & Equivalents
$1.92B
Debt / Equity
0.00×
Net Margin
10.0%
Shares Outstanding
553.08M sh
Source: 10-K · filed 2026-02-18 · accession 0002035989-26-000017

Short Interest & Short Volume

1.95 days to cover

FINRA reported short interest of 9,740,425 shares in AMRZ as of the September 15, 2026 settlement, a 6.0% increase from the prior period — about 1.9 days to cover at its recent average daily volume. On October 2, 2026, 69.6% of AMRZ volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,740,425 shares as of September 15, 2026
Change vs prior period▲ 6.0%
Days to cover1.95 at avg daily volume of 5,000,755
Daily short volume (FINRA facilities)69.6% of 1,353,102 shares on October 2, 2026
5-day average short volume61.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$37.26
52-week range · as of 2026-08-10 $37.26 – $65.94
Market cap
$20.38B
Volume
3.5M (0.8× avg)
3-mo avg 4.2M
Live data · 2026-10-05 03:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AMRZ - Latest Insights

AMRZ
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.29
Real-time Price: $37.26 info
Change: -$9.03 (-20%) info
Market Cap: $20.378B info
AMRZ
Aug 06, 2026, 4:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $50.59
Real-time Price: $37.26 info
Change: -$13.33 (-26%) info
Market Cap: $20.378B info
AMRZ
Aug 06, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $50.59
Real-time Price: $37.26 info
Change: -$13.33 (-26%) info
Market Cap: $20.378B info
AMRZ
Jul 20, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $50.41
Real-time Price: $37.26 info
Change: -$13.15 (-26%) info
Market Cap: $20.378B info
AMRZ
Jun 19, 2026, 10:30 AM EDT
Source: EQS
Importance Score:
8
Price at Filing: $55.35
Real-time Price: $37.26 info
Change: -$18.09 (-33%) info
Market Cap: $20.378B info
AMRZ
May 07, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $53.47
Real-time Price: $37.26 info
Change: -$16.21 (-30%) info
Market Cap: $20.378B info
AMRZ
Apr 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $53.94
Real-time Price: $37.26 info
Change: -$16.68 (-31%) info
Market Cap: $20.378B info
AMRZ
Apr 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $57.12
Real-time Price: $37.26 info
Change: -$19.86 (-35%) info
Market Cap: $20.378B info
AMRZ
Apr 14, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $59.96
Real-time Price: $37.26 info
Change: -$22.70 (-38%) info
Market Cap: $20.378B info
AMRZ
Mar 31, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $55.80
Real-time Price: $37.26 info
Change: -$18.54 (-33%) info
Market Cap: $20.378B info
AMRZ
Mar 12, 2026, 4:11 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $56.23
Real-time Price: $37.26 info
Change: -$18.97 (-34%) info
Market Cap: $20.378B info
AMRZ
Feb 27, 2026, 5:16 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $64.99
Real-time Price: $37.26 info
Change: -$27.73 (-43%) info
Market Cap: $20.378B info
AMRZ
Feb 18, 2026, 4:05 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $63.69
Real-time Price: $37.26 info
Change: -$26.43 (-41%) info
Market Cap: $20.378B info
AMRZ
Feb 17, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $59.50
Real-time Price: $37.26 info
Change: -$22.24 (-37%) info
Market Cap: $20.378B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets